A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients

NCT06595004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Low-back Pain

Interventions

DRUG: HCP1004
DRUG: RLD2401

Sponsor

Hanmi Pharmaceutical Company Limited